ATE298746T1 - Verfahren zur herstellung von substituierten benzimidazolverbindungen - Google Patents

Verfahren zur herstellung von substituierten benzimidazolverbindungen

Info

Publication number
ATE298746T1
ATE298746T1 AT01929529T AT01929529T ATE298746T1 AT E298746 T1 ATE298746 T1 AT E298746T1 AT 01929529 T AT01929529 T AT 01929529T AT 01929529 T AT01929529 T AT 01929529T AT E298746 T1 ATE298746 T1 AT E298746T1
Authority
AT
Austria
Prior art keywords
substituted benzimidazole
benzimidazole compounds
producing substituted
compounds
producing
Prior art date
Application number
AT01929529T
Other languages
English (en)
Inventor
Stephen Freeman
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE298746T1 publication Critical patent/ATE298746T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052Imidazole radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT01929529T 2000-04-11 2001-04-10 Verfahren zur herstellung von substituierten benzimidazolverbindungen ATE298746T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0008939.1A GB0008939D0 (en) 2000-04-11 2000-04-11 Process for preparing substituted benzimidazole compounds
PCT/EP2001/004080 WO2001077083A1 (en) 2000-04-11 2001-04-10 Process for preparing substituted benzimidazole compounds

Publications (1)

Publication Number Publication Date
ATE298746T1 true ATE298746T1 (de) 2005-07-15

Family

ID=9889715

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01929529T ATE298746T1 (de) 2000-04-11 2001-04-10 Verfahren zur herstellung von substituierten benzimidazolverbindungen

Country Status (9)

Country Link
US (4) US7101994B2 (de)
EP (2) EP1584620A1 (de)
JP (2) JP4841793B2 (de)
AT (1) ATE298746T1 (de)
AU (1) AU2001256272A1 (de)
DE (1) DE60111732T2 (de)
ES (1) ES2243488T3 (de)
GB (1) GB0008939D0 (de)
WO (1) WO2001077083A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2349616A1 (en) 1998-12-04 2000-06-15 Neurosearch A/S New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
EP1511736A4 (de) * 2002-06-07 2006-06-07 Cortical Pty Ltd Therapeutische moleküle und verfahren 1
WO2007064932A2 (en) * 2005-12-02 2007-06-07 Bayer Healthcare Llc. Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
US7655004B2 (en) 2007-02-15 2010-02-02 Ethicon Endo-Surgery, Inc. Electroporation ablation apparatus, system, and method
US8888792B2 (en) 2008-07-14 2014-11-18 Ethicon Endo-Surgery, Inc. Tissue apposition clip application devices and methods
US8157834B2 (en) 2008-11-25 2012-04-17 Ethicon Endo-Surgery, Inc. Rotational coupling device for surgical instrument with flexible actuators
US20110098704A1 (en) 2009-10-28 2011-04-28 Ethicon Endo-Surgery, Inc. Electrical ablation devices
US8546344B2 (en) 2010-10-28 2013-10-01 Viropharma Incorporated Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole
US9254169B2 (en) 2011-02-28 2016-02-09 Ethicon Endo-Surgery, Inc. Electrical ablation devices and methods
US9233241B2 (en) 2011-02-28 2016-01-12 Ethicon Endo-Surgery, Inc. Electrical ablation devices and methods
CN102952104A (zh) * 2011-08-17 2013-03-06 黑龙江省松花江药业有限公司 一种呋喃类化合物
US9427255B2 (en) 2012-05-14 2016-08-30 Ethicon Endo-Surgery, Inc. Apparatus for introducing a steerable camera assembly into a patient
US9545290B2 (en) 2012-07-30 2017-01-17 Ethicon Endo-Surgery, Inc. Needle probe guide
US10314649B2 (en) 2012-08-02 2019-06-11 Ethicon Endo-Surgery, Inc. Flexible expandable electrode and method of intraluminal delivery of pulsed power
US9277957B2 (en) 2012-08-15 2016-03-08 Ethicon Endo-Surgery, Inc. Electrosurgical devices and methods
US10098527B2 (en) 2013-02-27 2018-10-16 Ethidcon Endo-Surgery, Inc. System for performing a minimally invasive surgical procedure
PL4475844T3 (pl) * 2022-10-12 2025-11-12 Takeda Pharmaceutical Company Limited Sposób otrzymywania maribawiru

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3839743A1 (de) 1988-11-25 1990-05-31 Hoechst Ag Verfahren zur herstellung von benzimidazolonen
KR0167346B1 (ko) * 1989-06-09 1999-01-15 로버트 에이. 아미테이지 중추신경계 활성을 갖는 헤테로사이클릭 아민
US5248672A (en) 1990-11-01 1993-09-28 The Regents Of The University Of Michigan Polysubstituted benzimidazole nucleosides as antiviral agents
GB9205071D0 (en) 1992-03-09 1992-04-22 Wellcome Found Therapeutic nucleosides
GB9413724D0 (en) 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides
HUT77440A (hu) 1994-09-09 1998-04-28 The Regents Of The University Of Michigan Karbociklusos gyűrűhöz kapcsoló benzimidazolokat tartalmazó vírus-ellenes nukleozid analógok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
DE69624827T2 (de) 1995-08-18 2003-09-04 The Regents Of The University Of Michigan, Ann Arbor 5'-substitutierte-ribofuranosyl benzimidazolen als antivirale.
GB9600143D0 (en) 1996-01-05 1996-03-06 Wellcome Found Therapeutic compounds
GB9600142D0 (en) 1996-01-05 1996-03-06 Wellcome Found Chemical compounds
EP1019425A1 (de) 1996-01-23 2000-07-19 The Regents Of The University Of Michigan Modifizierte benzimidazole-nukleoside als antivirale arzneimittel
CA2280761A1 (en) 1997-02-13 1998-08-20 Stanley Dawes Chamberlain Benzimidazole derivatives
BR9810745A (pt) 1997-06-10 2001-03-13 Glaxo Group Ltd Derivados de benzimidazol
NZ502882A (en) 1997-07-30 2002-02-01 Glaxo Group Ltd Lyxofuranosyl benzimidazoles as antiviral agents
GB9807355D0 (en) 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
GB9807354D0 (en) 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
GB9815696D0 (en) * 1998-07-20 1998-09-16 Pfizer Ltd Heterocyclics

Also Published As

Publication number Publication date
EP1272473B1 (de) 2005-06-29
EP1272473A1 (de) 2003-01-08
EP1584620A1 (de) 2005-10-12
JP2003530385A (ja) 2003-10-14
ES2243488T3 (es) 2005-12-01
US7514568B2 (en) 2009-04-07
DE60111732D1 (de) 2005-08-04
WO2001077083A1 (en) 2001-10-18
JP2011173906A (ja) 2011-09-08
US7101994B2 (en) 2006-09-05
US7375235B2 (en) 2008-05-20
AU2001256272A1 (en) 2001-10-23
JP5192061B2 (ja) 2013-05-08
US20080188668A1 (en) 2008-08-07
US20030191127A1 (en) 2003-10-09
JP4841793B2 (ja) 2011-12-21
US20090187015A1 (en) 2009-07-23
US7858773B2 (en) 2010-12-28
DE60111732T2 (de) 2006-05-04
US20050261211A1 (en) 2005-11-24
GB0008939D0 (en) 2000-05-31

Similar Documents

Publication Publication Date Title
DE60111732D1 (de) Verfahren zur herstellung von substituierten benzimidazolverbindungen
ATE468309T1 (de) Verfahren zur herstellung von olefinen
ATE425136T1 (de) Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen
ATE414077T1 (de) Verfahren zur herstellung von 1-ä(benzimidazol-1- yl)chinolin-8-ylüpiperidin-4-ylaminderivaten
DE60234952D1 (de) VERFAHREN ZUR HERSTELLUNG VON HEXAHYDROFUROc2,3-BÜFURAN-3-OL
DE60105732D1 (de) Verfahren zur Herstellung von 3-l-Menthoxypropan-1,2-diol
DE60206996D1 (de) Verfahren zur Herstellung von 3-l-Menthoxypropan-1,2-diol
ATE286011T1 (de) Verfahren zur herstellung von 1-octen
ATE537173T1 (de) Verfahren zur herstellung von cucurbiturilen
ATE506351T1 (de) Verfahren zur herstellung von 10,11-dihydro-10- oxo-5h-dibenzoäb,füazepin-5-carboxamid
ATE287882T1 (de) Verfahren zur herstellung von imidazolverbindungen
ATE358172T1 (de) Verfahren zur herstellung von olefinen.
DE602004004677D1 (de) Verfahren zur herstellung substituierter 5-amino-pyrazolo-ä4,3-eü-1,2,4-triazoloä1,5-cüpyrimidine
DE502005000428D1 (de) Verfahren zur Herstellung von 1,2-Diaminocyclohexan-Platin(II)-Komplexen
DE60210778D1 (de) Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen
ATE374757T1 (de) Verfahren zur herstellung von (1,4,5)- oxadiazepinderivaten
ATE424892T1 (de) Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
ATE332905T1 (de) Verfahren zur herstellung von acylphosphinoxiden
ATE252589T1 (de) Aluminosiloxanverbindungen und verfahren zu ihrer herstellung
ATE281434T1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
DE602004030571D1 (de) Verfahren zur herstellung optisch aktiven 1-alkyl-substituierter 2,2,2-trifluorethylamins
ATE396166T1 (de) Verfahren zur herstellung von 2,3-cis- substituierten 2-arylpropenalen
ATE255085T1 (de) Verfahren zur drucklosen herstellung von alpha, alpha-dimethylphenylessigsäure aus alpha, alpha- dimethylbenzylcyanid
DE60230097D1 (de) Verfahren zur herstellung von 1,5-diaminonaphthalinen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties